One study has previously found a reduction in CSF α‐syn during a follow‐up of approximately 2 years in PD with short disease duration.25 We found that both CSF α‐syn and tau mainly increase during the later stages of the disease as well as in the more severe phases of PD, when the neurodegeneration is probably more widespread. The gene discussed is MAPT; the disease is Parkinson disease.